MedPath

Sexuality After Reduction Mammaplasty

Not Applicable
Completed
Conditions
Sexual Function
Depression
Registration Number
NCT01020422
Lead Sponsor
Daniela Francescato Veiga
Brief Summary

The aim of this study is to determine the impact of reduction mammaplasty on sexuality and depression predictors in women with macromastia.

Detailed Description

Breast hypertrophy is a common condition among women. Reduction mammaplasty is an effective and well established procedure performed for the relief discomfort associated with breast hypertrophy. Female breasts play an important role in sexuality, thus, the main purpose of this study is to determine whether reduction mammaplasty could influence sexual function and depression predictors on women with breast hypertrophy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • breast hypertrophy
  • candidate to reduction mammaplasty
  • healthy volunteer with normal volume breasts (control group)
  • body mass index under 30Kg/m2
Exclusion Criteria
  • pregnancy, delivery or breast feeding during the last 12 months
  • body mass index over 30Kg/m2
  • breast cancer history
  • previous breast surgery
  • hard smoking

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Sexual function6 months

Sexual function will be assessed by the Female Sexual Function Index (FSFI), pre and 6 months postoperatively.

Secondary Outcome Measures
NameTimeMethod
depression predictors6 months

Depression predictors will me assessed by the Beck Depression Inventory (BDI) pre- and 6 months postoperatively.

Trial Locations

Locations (1)

Hospital das Clínicas Samuel Libânio - UNIVÁS

🇧🇷

Pouso Alegre, Minas Gerais, Brazil

Hospital das Clínicas Samuel Libânio - UNIVÁS
🇧🇷Pouso Alegre, Minas Gerais, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.